NEUROCRINE BIOSCIENCES INC (NBIX) Operating cash flow 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$782.7MFY2025 · since FY2016: -$106.2M → $782.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $782.7M | +31.5% |
| FY2024 | $595.4M | +52.7% |
| FY2023 | $389.9M | +14.9% |
| FY2022 | $339.4M | +32.3% |
| FY2021 | $256.5M | +12.3% |
| FY2020 | $228.5M | +55.4% |
| FY2019 | $147.0M | +45.0% |
| FY2018 | $101.4M | +207.5% |
| FY2017 | -$94.3M | +11.2% |
| FY2016 | -$106.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice